Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

European Commission Issues New GMP Guidelines for Advanced Therapies

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:Drug Industry Daily

The European Commission released new GMP guidelines for manufacturers of advanced therapy medicinal products that adapts existing European Union GMP guidelines to the specific characteristics of ATMPs and calls for…

Continue ReadingEuropean Commission Issues New GMP Guidelines for Advanced Therapies

Judge Denies New Lawsuit for Parents Who Claimed Depakote Birth Defects

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:Drug Industry Daily

An Ohio federal judge denied a new trial to plaintiffs in a lawsuit against Abbott Laboratories who claimed their son was born with birth defects because the company failed to…

Continue ReadingJudge Denies New Lawsuit for Parents Who Claimed Depakote Birth Defects

FDA Guidance Details Product Tracing Exemptions Under the DSCSA

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:Drug Industry Daily

The FDA released a draft guidance explaining the circumstances when packages and cases are exempted from certain requirements of the 2013 Drug Supply Chain Security Act. Source: Drug Industry Daily

Continue ReadingFDA Guidance Details Product Tracing Exemptions Under the DSCSA

Supreme Court Divided on Future of the PTAB

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:Drug Industry Daily

The Supreme Court appeared divided Monday on the constitutionality of the PTO’s patent re-examination process of inter partes review — in a debate with wide implications for drugmakers on whether…

Continue ReadingSupreme Court Divided on Future of the PTAB

Merck Plots 950-Job R&D Hub in London

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

The move is in part related to Brexit, the UK's exit from the European Union. Source: BioSpace

Continue ReadingMerck Plots 950-Job R&D Hub in London

3 Top Diabetes Biotechs to Buy Into Right Now

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Diabetes is huge problem for Americans. Source: BioSpace

Continue Reading3 Top Diabetes Biotechs to Buy Into Right Now

Why Shire Should Spin Off Its Neuroscience Biz and Merge With This Maryland Pharma

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Kenneth Pittman, writing for Seeking Alpha, takes a look at why Shire is thinking of unloading its neuroscience division and suggesting an alternative. Source: BioSpace

Continue ReadingWhy Shire Should Spin Off Its Neuroscience Biz and Merge With This Maryland Pharma

Teva Expected to Fire Up to 1,700 Workers in Israel, U.S.

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

News of the layoffs comes hard on the heels of the company's credit rating having been cut to junk status by Fitch Rating. Source: BioSpace

Continue ReadingTeva Expected to Fire Up to 1,700 Workers in Israel, U.S.

Teva Shakes Up C-Suite in Restructuring

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Since taking over at Teva earlier this fall, Kare Schultz has been swiftly moving to shore up the finances and pay down the massive debts of the beleaguered pharmaceutical company.…

Continue ReadingTeva Shakes Up C-Suite in Restructuring

Biogen Forges $278M MS Tie-Up With Alkermes

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700. Source: BioSpace

Continue ReadingBiogen Forges $278M MS Tie-Up With Alkermes
  • Go to the previous page
  • 1
  • …
  • 246
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.